Biomarkers improves prognostic and mortality prediction in pneumonia

---

Original Article

Author Details : D Danis Vijay, S Jayanthi*, N Meenakshi

Volume : 5, Issue : 4, Year : 2018

Article Page : 430-435

https://doi.org/10.18231/2394-5478.2018.0089

Suggest article by email

Get Permission

---

Abstract

Pneumonia exhibits mortality rates, between 20% and 50% in severe cases. Biomarkers are useful tools for antibiotic therapy modifications as well as diagnosis, prognosis and follow-up treatment of pneumonia. This review presents the biological and clinical features of various biomarkers in Pneumonia patients, including C-reactive protein, Procalcitonin, Coceptin, D-dimers, MRpro-ADM, (Mid-regional pro adrenomedullin), Corisol, Endothelin-1, Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1), Adrenomedullin, Endotoxin, Mid regional Pro-Atrial Natriuretic Peptide (MR-proANP), TNF-? Polymorphisms, Pentraxin 3.

Keywords: Pneumonia, Community-acquired, Hospital-acquired, Ventilator-associated pneumonia (VAP), Biomarkers, Point of care testing.

How to cite : Vijay D D, Jayanthi S, Meenakshi N, Biomarkers improves prognostic and mortality prediction in pneumonia. Indian J Microbiol Res 2018;5(4):430-435

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.